Tuesday, August 3, 2021
Home Breaking News ISW Holdings Announces Elimination of More Than $2.4M (92%) of Outstanding Convertible...

ISW Holdings Announces Elimination of More Than $2.4M (92%) of Outstanding Convertible Debt

LAS VEGAS, April 07, 2021 (GLOBE NEWSWIRE) — via InvestorWire – ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, is thrilled to announce that the Company has signed an agreement (the “Agreement”) with GPL Ventures (“GPL”) to eliminate over $2.4 million in convertible promissory notes.

The Agreement covers all convertible debt held by GPL and represents more than 92% of the Company’s outstanding convertible debt obligations.

“This is a huge step,” commented Alonzo Pierce, president and chairman of ISW Holdings. “We are making good on our anti-dilution pledge announced last year and taking strong action to reduce or completely eliminate toxic debt and dilution risk from the equation for our shareholders. This enormous step prevents millions of shares from coming onto the market. We were able to take this step as a direct result of strong operational performance and a significantly improved outlook ahead.”

The Company notes that all of the outstanding capital obligation to GPL was subject to conversion at a significant discount to the stock’s current trading levels, potentially followed by immediate liquidation by GPL. However, as a result of the Company’s move to eliminate the obligation, no related conversion or liquidation will take place.

The Company continues to move forward with the commitments made in its anti-dilution initiative, as announced in December 2020. Since that announcement, the Company has reduced outstanding shares by nearly 25%, reduced authorized shares by 88% down to 60 million, and eliminated over $3.4 million (or 94%) of outstanding convertible debt.

About ISW Holdings
ISW Holdings, Inc. (ISWH), based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. Our expertise lies in strategic brand development, early growth facilitation, as well as brand identity through our proprietary procurement process. Together, with our partners, we seek to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. We are able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space; and the partnership has a vitally needed patent now pending.

For more information, visit www.iswholdings.com .

Forward-Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could,” “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Company Contact:
info@ISWHoldings.com


Public Relations
EDM Media, LLC
https://edm.media

Corporate Communications:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com


Disclaimer

This article is for the purposes of solicitation subscriptions for this website. This website expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. This website or it’s authors do not own any shares of ISW Holdings Inc. (ISWH) and does not buy, sell, or trade any shares of (ISWH). This article does not provide a professional analysis of a (ISWH) financial position. (ISWH) financial position and all other information regarding the featured Company should be verified directly with (ISWH). Please read our full disclaimer for more detailed information.

Most Popular

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient Centric...

NxGen Brands, Inc. Enters Into A Definitive Agreement To Acquire 100% Of Healthcard LLC; Acquisition Brings Company Ownership Of Proprietary Patent Pending Patient...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording &...

NxGen Brands, Signs Letter of Intent (LOI) to Acquire HealthCard, Technology Company That Has Patent Pending Registration for Patient Centric Universal Health Recording...

Nutra Pharma Announces that Diverse Health Services has Added Nyloxin to Their Product Offerings

Diverse Health Services, an industry leader in Chiropractic care and Alternative Medicine, announced the addition of the Nyloxin(R) line of pain relief...

Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs

Advertisement

Subscribe to our Stock News Alerts

Mobile is not required however if you want the fastest
delivery be sure to add your mobile.

Subscribe to our News Alerts
Loading